Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38374
CAS Number:
146939-27-7
Ziprasidona
Purity:
≥ 98 % (HPLC)
Documents
$83.42 /100 mg
Tamaño
Request Bulk Quote
Información del producto

Ziprasidone is an atypical antipsychotic medication primarily used in the treatment of schizophrenia and bipolar disorder. This compound is recognized for its unique mechanism of action, which involves the modulation of various neurotransmitter systems, including serotonin and dopamine receptors. Its efficacy in managing symptoms of psychosis and mood stabilization makes it a valuable option for healthcare professionals. Ziprasidone is particularly noted for its favorable side effect profile compared to traditional antipsychotics, allowing for improved patient compliance and quality of life.

In addition to its therapeutic applications, Ziprasidone has been the subject of extensive research, exploring its potential in treating other psychiatric conditions and its role in combination therapies. Its solubility and stability in various formulations further enhance its versatility in pharmaceutical development. Researchers and clinicians alike appreciate Ziprasidone for its ability to provide effective symptom relief while minimizing adverse effects, making it a significant compound in modern psychiatric treatment.

Número CAS
146939-27-7
Fórmula molecular
C21H21ClN4SO
Peso molecular
412.94
Número MDL
MFCD00866661
Punto de fusión
218 - 224 °C
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
146939-27-7
Fórmula molecular
C21H21ClN4SO
Peso molecular
412.94
Número MDL
MFCD00866661
Punto de fusión
218 - 224 °C
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Ziprasidone is widely utilized in research focused on

  • Treatment of Schizophrenia: This medication is primarily used to manage symptoms of schizophrenia, helping patients to stabilize their mood and reduce hallucinations.
  • Bipolar Disorder Management: It is effective in treating acute manic or mixed episodes associated with bipolar disorder, providing relief and improving overall quality of life.
  • Adjunct Therapy: In combination with other medications, it can enhance treatment outcomes for patients with resistant forms of depression, offering a more comprehensive approach to mental health care.
  • Cardiovascular Safety: Compared to some antipsychotics, it has a lower risk of metabolic side effects, making it a safer option for patients with cardiovascular concerns.
  • Research on Neurotransmitter Activity: It is used in clinical studies to explore its effects on neurotransmitter systems, contributing to a better understanding of mental health disorders and potential new treatments.

Citas